oral glp-1 weight loss Orforglipron Is Approved for Obesity FDA Approves Oral Semaglutide as
Description
2024;8:bvae197

36 , 130143 e135 (2024)

Lifestyle Med
The three glucose-lowering medications are common second-line therapies recommended by the guidelines [8, 9]